Karol Sikora

Karol is a Medical Director of Cancer Partners UK, which is creating the largest independent cancer network in the UK. He is Consultant Oncologist at Hammersmith Hospital, London and he chairs the scientific advisory board of Source Bioscience PLC, Britain’s leading cancer diagnostic company. He is Dean of Britain’s first independent Medical School at the University of Buckingham and is a Fellow of Corpus Christi College, Cambridge. Karol has published over 300 papers and written or edited 20 books including Treatment of Cancer – the standard British postgraduate textbook now going to its fifth edition and most recently The Economics of Cancer Care. He is the founding editor of Gene Therapy and Cancer Strategy, and remains an adviser to the World Health Organisation. He currently directs a cancer drug donation program in Africa.

Peter is the Head of the Pharmacy Department, King’s College London. Peter Hylands has many years’ experience in pharmacological research and development, with an emphasis on the isolation and structural determination of novel bioactive compounds, both in academia and industry. He has led multi-disciplinary research programmes in Europe, the Americas and various Asian countries and has been an invited speaker all over the world. Peter has published several articles in peer reviewed journals, written books and filed patent applications.

Jane Mellor

Jane read bacteriology and virology at the University of Manchester and received her PhD from the University of Reading. She started her career as a post-doctoral research scientist at the University of Oxford. She later became a research fellow at Wolfson and Exeter colleges at the University. In 1989, she became the Wellcome Trust senior research fellow in basic biomedical science. Jane has published more than 70 articles in peer –reviewed journals and in 2009, for her achievements in studies of epigenetics and regulated gene expression Jane was elected a Fellow of the European Molecular Biology Organization (EMBO). She was created the first professor of Epigenetics at the University of Oxford in 2008.

Lucien Peng Jin Ooi

Lucien is the Deputy Director at the National Cancer Centre, Singapore and the Chairman, Division of Surgery, at Singapore General Hospital. He was made a Fellow of Royal College of Surgeons of Edinburgh, the Royal College of Physicians and Surgeons of Glasgow, as well as the International College of Surgeons. He has a doctorate in Medicine awarded in 2001. Lucien has a sub-specialty interest in hepatobiliary and pancreatic surgery and as part of a distinguished career as immediate past Head of Department of Surgical Oncology in Singapore at the National Cancer Centre Singapore, he oversaw a department of more than 30 senior surgeons of various sub-specialties and was actively involved in advancing the specialty of surgical oncology. Lucien has been extensively consulted and sits on the panel of many illustrious international advisory boards and committees including those in the Ministry of Health.

Claudio has over 20 years’ experience in immunology, drug development, personalised medicine, and biomarkers. Previously, he was Global Head of Clinical Immunology & Biomarkers at Pfizer, and currently holds an Honorary Faculty position at the King’s College School of Medicine, London. Claudio has also consulted and sat on many distinguished international advisory boards and committees including the Medical Research Council (UK), F-NIH Biomarkers Consortium, Innovative Medicine Initiative (IMI-EU) and the PML Consortium.

Prior to joining Pfizer, Claudio has served in faculty roles at Harvard University, Johns Hopkins University, University College London and Rome University. Later in his career he held different senior roles at Wyeth, Novartis, Fresenius and Roche. He has also authored over two hundred papers in peer reviewed journals and co-edited three books in the field of personalised medicine. Claudio has received a doctorate in Medicine from Italy and a Ph.D from the University College London. Claudio has also specialist diplomas in Clinical Immunology and Respiratory Medicine from the University of Rome and has also been awarded a fellowship of the Royal College of Pathologists, London.